secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tevogen Bio Holdings Inc. (TVGN)
CIK:        0001860871
Form:       8-K
Filed at:   2023-09-29T23:59:59+00:00
Accession:  0001493152-23-034750
Event type: regulatory
Sentiment:  positive
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Semper Paratus regains Nasdaq MVLS compliance effective Sept 28, 2023
---------------------------------------------------------------------

- Company received Nasdaq letter Sept 28, 2023 confirming regained compliance with MVLS Rule (minimum $50M market value).
- Non-compliance notice received April 7, 2023; initial cure period ran to Oct 2, 2023.
- MVLS exceeded $50M for ten consecutive business days from Sept 14 to Sept 27, 2023.
- Compliance regained; delisting risk from Nasdaq Global Market is removed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860871/000149315223034750/0001493152-23-034750-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860871/000149315223034750/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-034750

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer